{
    "Trade/Device Name(s)": [
        "ARCHITECT\u00ae Anti-TPO Immunoassay",
        "ARCHITECT\u00ae Anti-TPO Calibrators",
        "ARCHITECT\u00ae Anti-TPO Controls"
    ],
    "Submitter Information": "Fisher Diagnostics",
    "510(k) Number": "K052407",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZO",
        "JJX",
        "JIT"
    ],
    "Summary Letter Date": "July 18, 2006",
    "Summary Letter Received Date": "September 2, 2005",
    "Submission Date": "August 31, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5870",
        "21 CFR 862.1660",
        "21 CFR 862.1150"
    ],
    "Regulation Name(s)": [
        "Thyroid Autoantibody Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "endocrine"
    ],
    "Analyte(s)": [
        "Thyroid peroxidase autoantibodies (Anti-TPO)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT\u00ae System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)",
        "Microparticle immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Anti-TPO immunoassay and associated calibrators and controls for quantitative detection of thyroid peroxidase autoantibodies in human serum and plasma",
    "Indications for Use Summary": "Aids in the diagnosis of autoimmune thyroid disease by quantitatively measuring IgG-class thyroid peroxidase autoantibodies in human serum and plasma using the ARCHITECT system",
    "fda_folder": "Immunology"
}